A Form 4 filed on September 15, 2026 reports that Saar Dotan, Executive Vice President of Countries and Business Development at ZIM Integrated Shipping Services Ltd., disposed of ordinary shares on September 14, 2026, following a net-basis stock option exercise.
Director Michael J. Nauman filed a Form 4 with the SEC on September 15, 2026, disclosing a purchase of Class A Common Stock of Matthews International Corp on September 11, 2026.
A Form 4 filed on September 15, 2026 with the U.S. Securities and Exchange Commission reports that Han Yunjie, a director of ZKH Group Ltd (NYSE:ZKH), disposed of 9,289,000 Class A ordinary shares on September 11, 2026.
Innodata Inc. filed a Form 8-K on September 15, 2026, disclosing that its Board of Directors elected Admiral Michael S. Rogers as an independent director, effective September 10, 2026.
Five very different Nasdaq-listed names, a tax-compliance software vendor, a lidar developer, an autonomous-driving chip supplier, a Chinese online insurance distributor and a voice-AI company, each show how AI is being priced into technology and services in September 2026. Vertex (NASDAQ:VERX), AEye (NASDAQ:LIDR), Mobileye …
Grouping biotech and health-technology stocks together can flatten some very real differences. In this list, one company is still spending to prove a drug works, another is banking hundreds of millions in quarterly product sales, and a third barely fits the biotech label at …
Healthcare investors spent the first half of 2026 watching biotech shake off a long malaise. As September opens, five Nasdaq-listed names capture the sector's range: Viatris (NASDAQ:VTRS), a global generics and specialty pharma heavyweight; Alkermes (NASDAQ:ALKS), a neuroscience developer with a closely watched orexin …
Five very different Nasdaq-listed companies, a healthcare-payments software leader, a fast-growing digital broker, a video-game publisher leaning into AI, and two quantum-adjacent science plays, offer a snapshot of how technology services now spans profitable cash machines and speculative moonshots as the September FOMC meeting …
Group these five names under a single financial services and fintech banner and the label starts to fray almost immediately. Only one, UP Fintech, is a straight-ahead online brokerage. Two are real-estate brokerages leaning hard into mortgage, title and technology. One is aCryptocurrencytreasury company …
Biotech spent much of the early 2020s as the market's problem child. In September 2026 the mood is noticeably different. A run of clinical readouts, a friendlier funding backdrop and renewed dealmaking appetite have pulledCapitalback toward the risk end of healthcare, and theNasdaqComposite, where …